
Abu Dhabi wrapped up the activities of “DoH Innovation Week 2023”, which included the announcement of the winners of the Healthcare Research and Innovation Grant and a series of panel discussions that tapped into several areas of innovation, such as, supporting entrepreneurs, design thinking, Artificial Intelligence (AI), and the National Innovation Strategy. This comes as part of DoH’s efforts to cement Abu Dhabi’s position as a leading destination for innovation in healthcare and a hub life sciences.
Recent Posts
Catalyzing Cardiovascular Health Innovation through Urban Interventions and Collaborative Research
Cardiovascular health innovation is at the forefront of the Innovative Health Initiative (IHI), the world's largest public-private partnership in life sciences, which succeeds the Innovative Medicines Initiative (IMI). Key projects from IHI Call 8, such as Cities@Heart, target cardiovascular dise...
EMA Approval Submission for Teclistamab Multiple Myeloma Monotherapy
Johnson & Johnson has submitted a Type II variation application to the European Medicines Agenc...
FDA Biosimilar Approval Reforms: Accelerating Access and Reducing Drug Costs
The US Food and Drug Administration (FDA) has introduced biosimilar approval reforms to accelerate development and adoption, tackling biologic drug costs that exceeded 50% of total US drug spending in 2024. These biosimilar approval reforms address burdensome criteria stifling uptake, despite 82 ...